The Landstuhl Regional Medical Center is an overseas military hospital operated by the U.S. Army. It is the largest American military hospital outside the continental United States.

There are 100 beds in Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen.

During the past decade, Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen" #1 collaborator was "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen" are "Acute Myeloid Leukemia" (1 trials) and "Acute Myeloid Leukemia (AML)" (1 trials). Many other conditions were trialed in "Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen" in a lesser frequency.

Most popular intervention types in "Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (2 trials), "All-trans retinoic acid" (1 trials), "All-trans retinoic acid (ATRA)" (1 trials), "Etoposid" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".